HIS29 Inherited And Acquired Bleeding Disorders II Flashcards
Case 1:
- 70 yo male
- Hyperlipidaemia, Dementia
- Spontaneous bruises / Haematoma over left thigh, both upper limb
- No bleeding history
- CT: Huge muscle haematoma over left thigh
- About few days of onset
- No drug history
- APTT prolong
- PT, platelet, WBC normal
- Hb drop of 2g from baseline (∵ bleeding)
- LRFT normal
Type of bleeding:
- Deep-seated bleeding
Inherited / Acquired:
- Acquired
Haemostatic system affected:
- Coagulation factor / Severe vWF deficiency
Complaint: - Isolated prolong APTT —> Only Intrinsic pathway affected —> Factor 8, 9, 11, 12, Contact factor deficiency / inhibitor, Lupus anticoagulant —> Heparin effects eliminated
Problem:
- Which exact coagulation factor
- Deficiency vs Inhibitor
- Lupus anticoagulant? —> Cause ***thrombosis in-vivo rather than bleeding (in-vitro) —> can be ruled out
Investigation:
- 1:1 Mixing test
- APTT —> 80.5
- APTT control —> 28.3
- APTT 1:1 mix —> 39.7
- APTT 1:1 mix, 37oC, 1 hour —> 83.6
—> ***APTT corrected at first then back to prolong —> Factor 8 inhibitor
- Factor assay: Factor 8c <1 (50-200) (grossly reduced)
Diagnosis: Acquired Haemophilia A (Acquired Factor 8 inhibitor)
Summary: Acquired clotting defect with clinical deep-seated bleeding tendency + Isolated APTT
—> Think of acquired Factor 8 inhibitor
1:1 Mixing test
Distinguish between Factor deficiency and Presence of inhibitor
4 measurements:
- APTT of patient
- APTT of normal person (control)
- APTT 1:1 mix (immediate mixing)
- APTT 1:1 mix, 37oC, 1 hour
Factor deficiency:
Normal pool plasma replace missing clotting factor
—> final mixed concentration must be >=50% (normal 100%, patient 0%)
—> as long as >30%
—> normal APTT (APTT correctable by normal plasma)
Presence of Inhibitor (i.e. Ab):
Inhibitors continue to destroy clotting factor in normal pool control plasma
—> APTT continue to prolong (no correction)
Immediate inhibitor (i.e. no correction of APTT at all):
- Lupus anticoagulant
- Factor 9 inhibitor (very rare)
Delayed acting (i.e. corrected APTT after immediate mixing, after 1 hour go back to prolonged APTT):
- Factor 8 inhibitor
—> showed time-dependent effect
Summary: Mixing test —> Correction of PT/APTT —> Yes —> Deficiency —> No —> Inhibitor (If no throughout (keep住長): Lupus anticoagulant; If yes then no (短—>長翻): Factor 8 inhibitor)
Acquired Haemophilia A (Acquired Factor VIII inhibitor)
- Production of ***AutoAb in adult life
—> inactivate Factor 8 - Both sexes affected equally (inherited Haemophilia A: Male predominant)
- Middle age
- Association with other autoimmune conditions, malignant disease, certain drugs, pregnancy has been recognised
Treatment:
- Treat acute bleeding immediately (can be severe)
- ***Immunosuppressants to eradicate inhibitor
Prognosis:
- Significant morbidity
- Significant mortality esp. if delayed treatment (41%)
Case 2:
- 59 yo man
- COPD, chronic smoker
- Haemoptysis
- CXR: Right upper zone patchy haziness, hyperinflation, no pneumothorax
- Sputum Acid Fast Bacilli ++++ —> TB
- No drug history
- No clinical bleeding, bruising / prolong bleeding from venepuncture site
- No abnormal bleeding history
- No family history
- LRFT normal
- PT prolong
- INR prolong
- APTT prolong
- Hb 23.3
- Hct 0.699
- WCC normal
- Plt normal
PT ↑, APTT ↑
Hb 23.3, Hct 0.699: Erythrocytosis (Polycythaemia due to chronic hypoxaemia from COPD)
—> Repeat test with appropriate citrate level —> Normal clotting time
Citrate bottle
Trisodium citrate (0.109M) as anticoagulant in citrate bottle —> bind Ca to prevent clotting
Most tubes collect blood (2.7 mL):anticoagulant (0.3 mL) in 9:1 ratio (fixed)
When Hct increased (e.g. Polycythaemia)
—> Actual plasma volume ↓ (if collect fixed amount of blood)
—> ↑ Anticoagulant to Plasma ratio
—> more Ca in plasma being bound away by Citrate
—> Falsely prolong clotting time
Recommended amount of citrate for different level of Hct
—> ↓ Citrate volume for ↑ Hct
Summary:
Correct ***blood:citrate ratio is very important when taking blood for clotting sample
—> falsely prolong clotting time if inadequately filled
Common pre-analytical pitfalls to affect clotting results
- Wrong patient, wrong specimen
- Heparin contamination during blood taking
- Haemolysed specimen
- Incorrect blood:citrate ratio
- Delay in transport (degradation of clotting factors)
—> If in doubt, repeat clotting profiles before treatment
Case 3:
- 51 yo male
- hypertension history
- RUQ pain 3 months ago, Acute cholecystitis, treated with Cefuroxime, Metronidazole
- Elective Cholecystectomy arranged
- clinically well, no bleeding
- Hb, WCC, Plt normal
- LFT normal
- RFT normal
- APTT ↑↑
- PT normal
- INR normal
- Heparin contamination excluded
- No bleeding history
- No family history
- No drug history
- Uneventful knee surgery for ACL repair previously
Complaint:
- Isolated ↑↑ APTT
—> Only Intrinsic pathway affected
—> Factor 8, 9, 11, 12, Contact factor, Lupus anticoagulant
1:1 mixing test:
- APTT fully correctable during immediate mixing and incubation after 1 hour
—> Factor deficiency
No bleeding tendency despite grossly prolong APTT
—> Not likely to be Factor 8, 9, 11 deficiency (highly associate with clinical bleeding)
Implication:
- Factor 12 / Contact factor deficiency
Further investigation:
- Factor assay:
—> Factor 8, 9, 11: normal
—> Factor 12: markedly ↓↓
Diagnosis:
- Severe Factor 12 deficiency
Factor XII deficiency
Deficiency of contact factors (Factor 12, Prekallikrein, Kallikrein, High MW Kininogen)
—> Prolonged APTT
Contact factors:
Function at step of initiation of intrinsic clotting pathway (In-vitro!!!) by reagent used to determine APTT
—> markedly prolong if contact factors absent
- **NOT associated with bleeding tendency
- **NO major role in normal physiological haemostasis
- Orientals have common polymorphism in Factor XII gene causing deficiency
Pre-op assessment of bleeding risks
Routine testing of clotting profile pre-operatively (esp. elective surgery) for assessment of bleeding risks is **NOT recommended
—> **Poor predictive value to predict bleeding risks by PT / APTT
In-vitro (only Plasma) vs In-vivo coagulation (***also involves Platelets + Endothelium)
- In-vitro tests do NOT accurately reflect in-vivo coagulation response
- ***LOW sensitivity to clinically significant bleeding disorder (e.g. vWD, Factor 13 deficiency)
- cause delay in surgical treatment
Therefore: - CBC (platelet count) - Bleeding symptoms - Drugs history - Family history of bleeding disorder - Past bleeding episode under haemostatic challenge (e.g. tooth extraction, menstruation) —> ***Higher predictive value!!!
Bleeding disorder cannot be detected by CBP, PT, APTT, TT, Fibrinogen tests
Pre-class quiz:
- 6 yo boy
- very severe post-op bleeding after simple knee surgery
- CBP normal
- PT, APTT, TT, Fibrinogen normal
Thrombocytopenia unlikely
—> ∵ CBP normal
Bleeding disorder cannot be detected by CBP, PT, APTT, TT, Fibrinogen tests:
- vWF deficiency (all parameters present normally —> need vWF assay)
- Platelet dysfunction (all parameters present normally —> need platelet function test)
(Both unlikely ∵ NO other clinical bleeding e.g. Mucocutaneous bleeding)
(unless very severe vWF deficiency —> Factor VIII deficiency —> affect APTT) - Blood vessels problem (unlikely ∵ no bruising over skin)
- ***Factor XIII deficiency (In-vitro test only detect up to fibrin monomer stage rather than polymer!!!)
—> need specialised test
Case 4:
- 60 yo male
- NPC received radiotherapy in 2000
- Complicated by hormone deficiencies
- Regular Fludrocortisone, Hydrocortisone, Testosterone replacement
- Anti-HT
- No anticoagulant
- No bleeding history
- No liver cirrhosis, other systems unremarkable
- LL pain
- Generalised bruising
- Left thigh swelling
- CT: huge muscle haematoma in left thigh
- Hb ↓ (∵ bleeding)
- Platelet normal
- Clotting profile: PT ↑↑, APTT ↑↑, TT normal, Fibrinogen normal
- Clotting result in 2012 normal —> acquired
Complaint:
- Generalised bruising
- Left thigh swelling
Type of bleeding:
- Deep-seated bleeding
Inherited / Acquired:
- Acquired
Haemostatic system affected:
- Coagulation factor / Severe vWF deficiency
—> Severe vWF deficiency —> unlikely ∵ it is congenital
Suggestion:
- Acquired Coagulation factor defect
—> most commonly due to ***liver cirrhosis (but not in this case)
1:1 mixing test:
- PT: correctable throughout
- APTT: correctable throughout
—> Factor deficiency
Liver cirrhosis: Unlikely
—> ∵ unremarkable P/E + TT / Fibrinogen normal (liver cirrhosis synthesise abnormal fibrinogen —> TT ↑, Fibrinogen ↓)
Causes:
Flowchart (from L28):
Prolong APTT —> Prolong PT —> Normal TT (i.e. NOT involve fibrinogen to fibrin)
1. Vit K deficiency / antagonists (Factor 2, 7, 9, 10)
2. Common pathway factor deficiency / inhibitors (Factor 2, 5, 10)
3. Multiple factor deficiencies involving multiple pathway
Further investigation:
- Factor assay:
—> Factor 2, 7, 9, 10 ↓↓
—> suggest presence of Vit K antagonists in body
Further history:
- NO warfarin history
—> but taking herbs before admission
—> toxicology lab for further investigations
Diagnosis:
- Superwarfarin poisoning (from rodenticides)
Treatment:
- High dose oral Vit K for long period of time to normalise clotting profile
Superwarfarin poisoning
- Class of rodenticide to overcome warfarin resistance in rats
- Long-acting
- Fat soluble
- Colourless, Tasteless, Odourless
- t1/2: from weeks to months (very long)
Lab investigations:
- ↑ PT, APTT
- TT, Fibrinogen normal
- absence of liver disease / warfarin therapy
—> results same as Vit K antagonist (e.g. Warfarin)
—> ↓ Vit K dependent factors (Factor 2, 7, 9, 10)
Summary
Case 1:
- 1:1 mixing test —> differentiation deficiency vs inhibitor
- Acquired Haemophilia A
Case 2:
- Polycythaemia —> High Hct —> falsely prolong clotting
- Citrate:plasma ratio importance
- Common pitfall of clotting test
Case 3:
- Factor 12 deficiency —> NOT cause physiological bleeding —> Limitation of lab test
- No need routine pre-op assessment of clotting file unless anticoagulant therapy previously
- Higher predictive value: Structural bleeding history
Pre-class quiz: - Factor 13 deficiency cannot be detected by lab test
Case 4:
- Pattern of Vit K dependent factors deficiency